Wed 25 Nov 2009 | 1:18 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc. (LXRX.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View LXRX on other exchanges
As of  24 Nov 2009
1.63USD
Price Change
+0.03
Percent Change
+1.88%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Tessmer, James 49 2009 Vice President - Finance & Accounting, Principal Accounting Officer
Brown, Philip 47 2008 Senior Vice President - Clinical Development
Sands, Arthur 47 1995 President, Chief Executive Officer, Director
Wade, Jeffrey 44 2000 Executive Vice President, General Counsel
Zambrowicz, Brian 46 2007 Executive Vice President, Chief Scientific Officer
Main, Alan 55 2007 Executive Vice President - Pharmaceutical Research
Lefkowitz, Robert 65 2001 Director
Nies, Alan 71 2003 Director
Palantoni, Frank 51 2004 Director
Wiltsey, Kathleen 53 2007 Director
Debbane, Raymond 54 2007 Director
Sobecki, Christopher 50 2007 Director
Amouyal, Philippe 50 2007 Director
Swain, Judith 60 2007 Director
Bansal, Ajay 47 2009 Chief Financial Officer, Executive Vice President - Corporate Development
Barker, Samuel 66 2005 Chairman of the Board